TLB Share Price

Open 0.75 Change Price %
High 0.75 1 Day -0.02 -2.82
Low 0.69 1 Week -0.04 -5.48
Close 0.69 1 Month -0.05 -6.76
Volume 4305 1 Year -0.42 -37.84
52 Week High 1.24
52 Week Low 0.51
TLB Important Levels
Resistance 2 0.75
Resistance 1 0.72
Pivot 0.71
Support 1 0.66
Support 2 0.63
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TBE 0.03 0.00%
CPG 16.13 7.03%
CPG 16.13 7.03%
YRI 4.08 -9.13%
FM 14.98 -5.61%
More..
TSE Canada Top Gainers Stocks
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
TVI 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
KAT 0.47 14.63%
KAT 0.47 14.63%
KOR 0.88 14.29%
KOR 0.88 14.29%
More..
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
YRB-A 0.08 -11.11%
S 1.18 -9.92%
S 1.18 -9.92%
CTU-A 0.19 -9.52%
YRI 4.08 -9.13%
ETG 0.82 -6.82%
ETG 0.82 -6.82%
ETG 0.82 -6.82%
MSV 1.39 -6.71%
More..

TearLab Corp (TSE: TLB)

TLB Technical Analysis 4
As on 17th Feb 2017 TLB Share Price closed @ 0.69 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.26 & Sell for SHORT-TERM with Stoploss of 0.78 we also expect STOCK to react on Following IMPORTANT LEVELS.
TLB Target for February
1st Target up-side 1.02
2nd Target up-side 1.16
3rd Target up-side 1.31
1st Target down-side 0.6
2nd Target down-side 0.46
3rd Target down-side 0.31
TLB Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.tearlab.com
TLB Address
TLB
7360 Carroll Road
Suite 200
San Diego, CA 92121
United States
TLB Latest News
Form 5 TearLab Corp For: Dec 31 Filed by: Wright Brock   StreetInsider.com   - 14th Feb 17
Tearlab Corp. (NASDAQ:TEAR) Now Counts First Light As A Holder   Small Cap Exclusive (press release)   - 12th Jan 17
BRIEF-Mathew Arens reports 6.6 pct passive stake in Tearlab Corp   Reuters   - 11th Jan 17
TearLab Corporation Reports Third Quarter and September Year-To-Date 2016 ...   GlobeNewswire (press release)   - 07th Nov 16
TearLab Corporation Comments on Shire plc FDA Approval of Xiidra ...   GlobeNewswire (press release)   - 13th Jul 16
Why This Analyst Sees TearLab Shares Tripling   Benzinga   - 12th Jul 16
CFO Moves: Express, Creative Artists Agency, and TearLab Corp.   Wall Street Journal (blog)   - 08th Jul 15
Don't Blink: TearLab Is Cutting It Close   Seeking Alpha   - 17th Jun 15
TearLab to Open Satellite Office in Southlake   Southlake Style   - 04th Mar 15
Why TearLab Corp. Shares Dipped   Motley Fool   - 13th Nov 13
Interactive Technical Analysis Chart TearLab Corp ( TLB TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on TearLab Corp
TLB Business Profile
TearLab Corp. operates as an ophthalmic device company in the United States. It is involved in developing and commercializing TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The company’s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corp. was founded in 1996 and is headquartered in San Diego, California.